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cardiometabolic profiles: a cross-sectional
compositional data analysis approach
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Claire Elizabeth Stewart4 and Gladys Leopoldine Onambele-Pearson1
Abstract
Background: Studies have seldom used Compositional Data Analysis (CoDA) to map the effects of sleep, sedentary
behaviour, and physical activity on older adults’ cardio-metabolic profiles. This study therefore aimed to illustrate
how sleep, sedentary behaviour, and physical activity profiles differ between older adult groups (60–89 years), with
‘low’ compared to those with ‘high’ concentrations of endocrine cardio-metabolic disease risk markers, using CoDA.
Method: Ninety-three participants (55% female) wore a thigh-mounted triaxial accelerometer for seven consecutive
free-living days. Accelerometer estimates of daily average hours of engagement in sedentary behaviour (SB),
standing, light-intensity physical activity (LIPA), sporadic moderate-vigorous physical activity (sMVPA, accumulated
with bouts between 1 and 10 min), 10-min moderate-vigorous physical activity (10MVPA, accumulated with bouts
≥10 min), in addition to self-reported sleeping hours were reported. Fasted whole blood concentrations of total
cholesterol, triglyceride, glucose, and glycated haemoglobin, and serum lipoprotein lipase (LPL), interleukin-6 (IL-6),
and procollagen III N-terminal propeptide were determined.
Results: Triglyceride concentration appeared to be highly dependent on 10MVPA engagement as the ‘low’ and
‘high’ concentration groups engaged in 48% more and 32% less 10MVPA, respectively, relative to the geometric
mean of the entire study sample. Time-use composition of the ‘low’ LPL group’s engagement in 10MVPA was 26%
less, while the ‘high’ LPL group was 7.9% more, than the entire study sample. Time-use composition of the ‘high’
glucose and glycated haemoglobin groups appeared to be similar as both engaged in more Sleep and SB, and less
10MVPA compared to the study sample. Participants with a ‘low’ IL-6 concentration engaged in 4.8% more Sleep
and 2.7% less 10MVPA than the entire study sample. Time-use composition of the Total Cholesterol groups was
mixed with the ‘low’ concentration group engaging in more Standing and 10MVPA but less Sleep, SB, LIPA, and
sMVPA than the entire study sample.
Conclusion: Older adults should aim to increase 10MVPA engagement to improve lipid profile and decrease SB
engagement to improve glucose profile.
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Background
Between 2011 and 2014, medication prescription for the
prevention and treatment of circulatory diseases within
the adult population increased 2.2 fold in England [1],
with 62–95% of adults above the age of 55 years taking
at least one prescribed drug per week for the treatment
or prevention of any condition [2]. These prescriptions
included medications such as lipid lowering, anticoagu-
lant and anti-fibrinolytic drugs; critically, many of these
drugs target metabolites that may be regulated by phys-
ical activity (PA) interventions [3–5]. For example, in
older adult cohorts (65–94 years), 3 х 60 min aerobic
sessions per week, for 8 months, at 60–80% of heart rate
reserve was sufficient to reduce total cholesterol and
triglyceride concentration [6]. Additionally, emerging-
evidence also suggests that changes in sedentary behav-
iour (SB) could affect metabolites, through physiological
mechanisms that are different from those for PA (specif-
ically of moderate to vigorous intensity [MVPA]) [7]. In
rodent modelling of SB, 6 h of hind limb unloading in
rats decreased oxidative skeletal muscle lipoprotein-lipase
(LPL) activity by 50% relative to ambulatory controls,
whereas, treadmill running (56m∙min− 1, 3.5 h·day− 1) did
not increase oxidative muscle LPL activity above that of
ambulatory controls but did in glycolytic muscle [7]. It is
suggested that SB targets post-transcriptional modification
of LPL, as LPL mRNA expression remained unchanged
during hind limb unloading [7]. Even though SB and PA
may act through independent mechanisms in the modula-
tion of cardio-metabolic disease, ultimately, it is the end-
point of the relevant metabolite that is of most interest to
the end-user. Therefore, it is argued that future studies
should consider SB and PA together, not in isolation, to
determine their cumulative effects on health status to re-
flect ‘real-world’ lifestyles.
Previous approaches to Sleep, SB, LIPA, and MVPA ana-
lysis have treated these behaviours as independent risk
factors for health status [8–10]. Such isolation of the behav-
iours in statistical analysis is inappropriate, due to the co-
dependent nature of time-use variables, and can lead to the
under/overestimation of the effects of Sleep, SB, LIPA, and
MVPA on health status [11]. These issues can be overcome
by using Compositional Data Analysis (CoDA) and present-
ing, for example, the geometric mean engagement in a be-
haviour (time-use component) as a standardised score,
relative to the geometric mean of all engaged time-use
components. This allows the standardised score of the
engagement in a particular time-use composition by a sub-
group to be presented as a log ratio, relative to the standar-
dised score of the engagement in the same time-use
composition intensity by the entire study sample (log ra-
tio = ln[centred geometric mean of sub-group ÷ centred
geometric mean of study sample]) [12–14]. CoDA is nor-
mally used to compare the time-use composition of two or
more groups, relative to the entire study sample and al-
though a relatively new form of analysis in sleep, sedentary
behaviour, and physical activity research, CoDA has pro-
vided interesting descriptive data. CoDA of the participants
from the NHANES 2005–06 cycle suggested those with a
relatively low high-density lipid (HDL-C) concentration en-
gaged in 9% less MVPA relative to the overall geometric
mean composition. Whereas, those with a healthy HDL-C
concentration engaged in 4% more MVPA relative to the
overall geometric mean composition [12].
The use of CoDA continues to grow within health
research however, the majority of CoDA studies to
date have focussed on adolescent to middle-age cohorts
[12, 13, 15–17]. Studies that have applied CoDA to older
adult cohorts have primarily focussed on adiposity, cardio-
respiratory fitness, cholesterol and glucose [18, 19]. There-
fore, the aim of this study was to illustrate which time-use
composition influences cardio-metabolic parameters in
older adults (60–89 years) as cardiovascular-metabolic
complications are one of the leading causes of death in
this age group [1]. The objective of this study was to
determine the difference in the time-use composition be-
tween older adults with ‘low’ and ‘high’ endocrine cardio-
metabolic disease-risk (ECMDR) profiles using CoDA. It
was hypothesised that time-use composition in the ‘high’
ECMDR profile sub-groups would illustrate a greater en-
gagement in SB and a lower engagement in PA relative to
the entire study sample geometric mean, which has been
shown in previous studies [12, 13].
The current study fits within Research Area 3 of the
VIRTUE Framework [11] as it addresses the need to “de-
termine the prevalence of the optimal time-use balance
among populations and specific population subgroups
[and] identify the most common unhealthy time-use pat-
terns in different populations” [11]. This has been pos-
sible as our research group previously developed and
utilised an accelerometer analysis package, which re-
ported variable suitable for time-use analysis [11], thus
fitting also within Research Area 1 of the VIRTUE
Framework.
Methods
First laboratory visit
The details of the first laboratory visit follows our previ-
ously published work [20, 21]. Briefly, older adults (60+
years) who did not suffer from an untreated cardiovascular
disease, had not sustained a mobility limiting injury within
the last 3months, did not require a walking aid (e.g. Zim-
mer frame), were non-diabetic, and had/were not suffering
from dementia or similar disease were recruited for the
cross-sectional epidemiology study, primarily from local
community groups in Cheshire, United Kingdom, between
January 2015 and June 2016. Study involvement was ap-
proved by the written informed consent of the participant
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and ethical approval was granted by the University Ethics
Subcommittee. Participants provided hard copies of their
most recent prescriptions to record which medications may
be influencing their cardiovascular-metabolic disease risk,
either directly or indirectly. These medications were cate-
gorised into blood pressure (BP) medication [mg∙day− 1],
lipid-lowering medication [mg∙day− 1], directly targeting
cardiovascular disease (CVD) medication [n∙day− 1], (in)dir-
ectly targeting CVD medication [n∙day− 1], and inflamma-
tory + (in)directly targeting CVD medication [mg∙day− 1].
Participants were fitted with a commercially available
tri-axial GeneActiv Original accelerometer (Activinsights
Ltd., Kimbolton, UK) on the thigh of their dominant leg
(anterior aspect at 50% of greater trochanter to femoral
condyle distance) using two waterproof adhesive patches
(Tegaderm Film, 3M, North Ryde, Australia). The accel-
erometer was worn for seven consecutive free-living
days, during this time; participants self-reported their
sleeping hours by recording the time they turned the
lights off to go to sleep at night and what time they
woke up to start their day within a sleep diary. The sleep
diary was used to estimate the daily average sleeping
hours of the participant, whilst the accelerometer esti-
mated the daily average engagement hours for the other
time-use components (see below for details).
The accelerometer data was recorded at a 60Hz fre-
quency and smoothed using 10-s epochs. In-house devel-
oped software, The Cheshire Algorithm for Sedentarism
(CAS), was used to calculate the time spent engaging in
each sleep, sedentary behaviour, and physical activity inten-
sity using Residual G (= √([standard deviation x axis]2 + [
standard deviation y axis]2 + [standard deviation z axis]2))
cut-off points, which were developed from a sub-group
(n = 20) of older adults from the current body of work
[20–22]. Behaviours were classified as SB or Standing by
CAS if the participant was in the seated/reclined position
or upright, respectively [23], and produced a Residual G
value, for at least 1 min, below the SB-LIPA cut-off point
(0.057 Residual G = 1.5 metabolic equivalent tasks). The
Cheshire Algorithm for Sedentarism classified a behaviour
as LIPA if the participant was upright and produced a Re-
sidual G value, for at least 1 min, that was above the SB-
LIPA cut-off point but below the LIPA-MVPA cut-off
point (0.216 Residual G = 3 metabolic equivalent tasks).
Any movements by the participant, whilst in the upright
position, that produced a Residual G value that was equal
to or above the LIPA-MVPA cut-off point, for at least 1
min, was classified as MVPA by CAS. Moderate-to-
vigorous physical activity was then further classified by
CAS into sporadic MVPA (sMVPA, MVPA time accumu-
lated using bouts that were between 1 and 10 continuous
minutes), and 10-min MVPA (10MVPA, MVPA time accu-
mulated using bouts of 10 continuous minutes or more).
This splitting of MVPA was done to align with the 10-min
criterion in the 2011 UK physical activity guidelines for
MVPA [24]. Inclusion in statistical analyses required at
least six 24-h days of data from the accelerometer, as a re-
sult three participants were removed from statistical ana-
lyses owing to insufficient amount of data.
Second laboratory visit
Whole blood cardio-metabolic analysis
Participants arrived to the laboratory in an overnight (>
10 h) fasted, hydrated state. Where appropriate, partici-
pants were asked to refrain from taking medication until
testing had been completed. All participants refrained
from taking medication prior to the completion of the
laboratory tests and all provided a 10mL venous blood
sample. Whole blood analyses of fasting plasma glucose,
total cholesterol, and triglycerides were performed im-
mediately using an Accturend Plus (Roche Diagnostics
Limited, Welwyn Garden City, UK) monitoring device
and Accutrend test strips (Roche Diagnostics Limited,
Welwyn Garden City, UK) [25]. Whole blood analysis of
glycated haemoglobin (HbA1c) was performed on a sub-
group of participants (n = 33) using boronate fluorescence
quenching (HbA1c 501 device and test cartridges, Hemo-
Cue, Ängelholm, Sweden). HemoCue 501 has shown good
reliability (Coefficient of Variation [CV] < 5.0%) and valid-
ity (Bland-Altman: 4.4 [95%CI -7.3, 16.2] mmol∙mol− 1)
compared to high performance liquid chromatography ion
exchange [26].
Remaining blood samples were stored on crushed ice
for less than 2 h before centrifugation at 1687 G for 5 min
(Z380, Hermle, Gosheim, Germany). Serum was harvested
and stored at − 20 °C in 1.00mL aliquots (Eppendorf Ltd.,
Hamburg, Germany) until further analyses.
Serum cardio-metabolic analyses
Commercially available enzyme-linked immunosorbent
assay kits were used to determine the concentration of
serum lipoprotein lipase (LPL) (Cell Biolabs Inc., California,
USA), procollagen III N-terminal propeptide (PIIINP) (Bio-
matik, Delaware, USA), and interleukin-6 (IL-6) (high-sensi-
tivity, Bio-Techne, Minnesota, USA) using a two-fold
sample dilution. Manufacturer reported LPL intra-assay CV
was 4% whereas it reached 13% in house. For PIIINP, manu-
facturer sample intra-assay CV was < 10%, which coincided
with in house data (6.5–9.6%). IL-6 manufacture intra-assay
CV was 7.8% whereas in house it ranged from 7.4–9.2%.
ELISA data were derived using a 96-well spectrophotometer
(EL808, BioTek, Vermont, USA) connected to a computer
running Gen5 v 1.11 software (BioTek, Vermont, USA).
Statistical analyses
Demographics
SPSS version 22 (IBM, New York, USA) was used for
statistical analysis. 1 × 5 independent analysis of variance
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(ANOVA) and bonferroni correction (Kruskall-Wallis
and Mann-Whitney U for non-parametric data) was
used to see whether participant demographics differed
between lustrums of age and determine whether CoDA
needed to be performed for age sub-groups or pooled
study sample. Data are presented as mean (standard de-
viation [SD]) or median (interquartile range [IR]) if rules
of parametricity are violated. Statistical significance was
set at p < 0.05.
Compositional data analysis
Participants were grouped into ‘low’ or ‘high’ concentra-
tion groups for each cardio-metabolic parameter based
on whether they were less than or equal to, or above the
recognised threshold concentration for the respective
cardio-metabolic marker (Table 1). Where threshold
concentrations from previous research could not be ap-
plied, the median (PIIINP) and mean (HbA1c) concen-
tration of the study sample were used as the threshold.
The HbA1c threshold of 6.5% [27] could not be applied
to the study sample as the participants did not display
diabetic symptoms and therefore every participants’
HbA1c percentages fell below 6.5%. Similarly, the 4780
pg·mL− 1 threshold [30] could not be applied as every
PIIINP concentration within the current study was
below this threshold.
Using Excel 2013 (Microsoft, Washington, USA), the
geometric mean (hrs∙day−1) was calculated for each
time-use composition for the entire study sample. The
grand geometric mean was further calculated for the en-
tire time-use composition data (Sleep + SB + Standing +
LIPA + sMVPA +10MVPA) of the entire study sample.
The study sample data were centred (ceno) by dividing
the geometric mean for each time-use composition by
the grand geometric mean of the study sample and then
dividing by the available time in a day (24 h). These steps
were then performed on the cardio-metabolic parameter
sub-groups (ceni) (‘low’ and ‘high’). The centred data for
each time-use composition, for each sub-group, was di-
vided by the centred data for the respective time-use
composition of the entire study sample as a log ratio
(ln[ceni ÷ ceno]). The log ratio represents the sub-
group’s engagement in a time-use composition relative
to the entire study sample’s standardised engagement in
the same time-use composition [12, 13].
Handling covariates
Analysis of covariance (ANCOVA) was performed using
SPSS version 22 (IBM, New York, USA) to determine
whether covariates, previously shown to be associated
with cardio-metabolic parameters [31–34] (BP medica-
tion [mg∙day− 1], lipid-lowering medication [mg∙day− 1],
directly targeting CVD medication [n∙day− 1], (in)directly
targeting CVD medication [n∙day− 1], and inflammatory
+ (in)directly targeting CVD medication [mg∙day− 1]),
influenced the concentration of the cardio-metabolic
parameters within the current study (Table 2). LPL was
found to be influenced by inflammatory + (in)directly
CVD targeting medication (p < 0.05). LPL data were ad-
justed for the aforementioned covariate and the partici-
pants were regrouped before CoDA was performed. No
other cardio-metabolic parameters were influenced by
the aforementioned covariates.
Handling ‘essential’ Zeros
Within CoDA, there are rounded zeros, which repre-
sent data that could not be measured due to the sen-
sitivity of the equipment used, and there are essential
zeros, which represent real values for a parameter. In
the current study, essential zeros were common in
time-use composition data, as many participants did
not engage in 10MVPA. It is not possible to log trans-
form zeros or calculate geometric means, therefore
they need to be accounted for so they still carry
weight in the analyses. One method is to remove all
the participants who have essential zero data, which
has been performed in previous studies [12, 13].
However, given the sample size of the current study
(n = 93), removal of participants would severely reduce
the power of the study and thus, is not deemed an
appropriate approach. Therefore, 0.1 was added to
every data point, then 0.1 was subtracted from the
geometric mean calculations [35] so the essential
zeros still carried weight in the analysis.
Sleep, sedentary behaviour, and physical activity co-
dependence
To determine the co-dependence between time-use com-
ponents, a variation matrix was used. A variation matrix
displays the variance in the study samples’ log-ratios for
each time-use composition comparison (Additional file 1:
Table S1). A variance close to zero would imply the
Table 1 Cardio-metabolic threshold values used to determine
participant groupings into ‘low’ and ‘high’ endocrine
concentration
Cardio-metabolic Parameter Threshold
Glucose 6.0 mmol∙l− 1 [27]
Total Cholesterol 5.0 mmol∙l− 1 [27]
Triglyceride 1.7 mmol∙l− 1 [27]
HbA1c 5.29%a
LPL 63.5 pg∙mL− 1 [28]
IL-6 2.29 pg∙mL−1 [29]
PIIINP 229.215 pg∙mL-1a
aMean % HbA1c used as the threshold. Median PIIINP concentration used as
the threshold
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amounts of time spent in the corresponding behaviours are
highly proportional and therefore, suggest a change in en-
gagement of one of those time-use compositions would
likely result in a change in engagement in the correspond-
ing time-use composition.
Results
The demographics of the 93 older adults who partici-
pated in the study (73.6 [7.17] years, 55% female) are
displayed in Table 3. Notably, there was no difference
between lustrum age groups for any of the cardio-
metabolic, time-use composition, or covariate parame-
ters. This therefore allowed follow up CoDA with pooled
data. For results on the variation matrix of time-use
components please see Additional file 1: Table S1.
Whole blood cardio-metabolic parameters
The time-use composition for ‘low’ and ‘high’ whole blood
cardio-metabolic parameter sub-groups is displayed in
Fig. 1a-d. Triglyceride concentration appears to be highly
dependent on 10MVPA engagement as the ‘low’ triglycer-
ide concentration group engaged in 48% more 10MVPA
relative to the geometric mean of the entire study sample
(Fig. 1a). It also suggests that reducing 10MVPA engage-
ment may result in a change to a ‘high’ triglyceride profile
more readily than the opposite. Indeed those with a ‘high’
triglyceride concentration only engaged in 32% less
10MVPA than the geometric mean of the entire study
sample, whereas those with a ‘low’ triglyceride concentra-
tion required a 48% greater engagement in 10MVPA com-
pared to the entire study sample (Fig. 1a). It appears that
differences in total cholesterol profile may be influenced
by most time-use components as those with a ‘low’ total
cholesterol profile engaged in less sleep (3.0%), SB (2.9%),
LIPA (7.1%), sMVPA (6.0%), and more standing (7.9%)
and 10MVPA (4.4%) than the entire study sample. The
opposite time-use composition was true for the ‘high’
total cholesterol concentration group (Fig. 1b). The
composition of the ‘high’ glucose and HbA1c groups
appeared to be similar as both engaged in more sleep
and SB, and less PA (excluding sMVPA) compared to
the entire study sample (Fig. 1c-d).
Serum cardio-metabolic parameters
Before correcting for covariate effects, LPL was heavily
influenced by 10MVPA, with a large difference in en-
gagement compared to the entire study sample (‘low’
LPL: 27% less 10MVPA, ‘high’ LPL: 11% more 10MVPA)
(Fig. 2a). Whereas the difference from the entire study
sample for the other time-use components did not
exceed 2.2% (Fig. 2a). Following normalisation for in-
flammatory + (in)directly targeting CVD medication, the
‘low’ LPL group’s engagement in 10MVPA was 26% less
while the ‘high’ LPL group was 7.9% more than the en-
tire study sample (Fig. 2b). Sleep appeared to be a main
determinant of IL-6 concentration as those in the ‘low’
and ‘high’ IL-6 group engaged in 4.8% more and 3.1%
less sleep compared to the entire study sample, respect-
ively. Whereas the other time-use components had a
lower difference in engagement compared to the entire
study sample (Fig. 2c). The results suggest that bouts of
MVPA above 10 mins are sufficient to stimulate an in-
flammatory response as the ‘high’ IL-6 group engaged in
2.7% more 10MVPA and 2.2% less sMVPA compared to
the entire study sample (Fig. 2c). PIIINP followed a simi-
lar composition to IL-6, with sleep displaying the great-
est difference from the entire study sample in both ‘low’
(6.2%) and ‘high’ (5.9%) groups compared to the other
time-use components.
Discussion
The findings of this study confirmed our hypothesis as
time-use composition in the ‘high’ ECMDR sub-group
illustrated a greater engagement in SB and a lower engage-
ment in PA relative to the entire study sample geometric
mean. Whereas the ‘low’ ECMDR sub-group engage in
more PA and less SB relative to the entire study sample
geometric mean which, in agreement with previous stud-
ies [12, 13]. However, the hypothesis was not confirmed
for IL-6 and PIIINP (when a median grouping threshold
was used), as participants within the ‘high’ sub-groups in
fact engaged in less SB and more PA.
Lipoprotein – LPL Axis
Lipoprotein lipase was one of the first identified cardio-
metabolic markers to illustrate “independent” effects of
Table 2 Influence of medication on cardio-metabolic parameters
Medication Cardio-metabolic Parameter
Glucose Triglyceride Total Cholesterol HbA1c LPL IL-6 PIIINP
BP 0.71 0.93 0.57 0.53 0.14 0.95 0.70
Lipid-lowering 0.36 0.47 0.84 0.63 0.46 0.81 0.53
Directly targeting CVD 0.94 0.06 0.69 0.27 0.89 0.24 0.59
(in)directly targeting CVD 0.64 0.32 0.90 0.68 0.31 0.76 0.35
Inflammatory + (in)directly targeting CVD 0.47 0.92 0.09 0.19 0.00* 0.71 0.88
Data presented as p value. * Bold - Covariate has a significant effect on a cardio-metabolic endocrine parameter concentration (p<0.05)
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SB and MVPA [7]. It was suggested that prolonged SB
targets oxidative skeletal muscle LPL activity whereas;
MVPA appears to primarily target glycolytic muscle LPL
activity [7]. LPL is responsible for the hydrolysis of tri-
glyceride into glycerol and fatty acid. Pre-heparin serum
LPL (measured in the current study) primarily repre-
sents inactive LPL as a dimer bound to isolated remnant
lipoproteins [36], which, in the presence of active LPL,
augments triglyceride hydrolysis and the uptake of very
low-density lipoproteins and cholesterol esters [37].
Therefore, reduced serum LPL concentration, similar to
muscle LPL activity, may lead to increased circulating
triglyceride concentration [38]. The comparison of time-
use composition between triglyceride and LPL groups
supports the LPL-triglyceride-PA complex as those in
the ‘high’ LPL concentration and ‘low’ triglyceride con-
centration groups both displayed a greater engagement
in 10MVPA (7.8 and 48.4%, respectively) compared to
the entire study sample. In addition, 10MVPA had the
greatest difference from the entire study sample, com-
pared to the other time-use components, for both LPL
and triglyceride, suggesting that these cardio-metabolic
markers are influenced more by 10MVPA rather than
any other time-use composition. This finding supports
that of a previous SB break study, which found 30 mins
of MVPA (which would be classified as 10MVPA in the
current study) maintained plasma triglyceride concentra-
tion (relative to baseline) following ingestion of a high
fat meal (35%) [39]. In addition, Engeroff, Füzéki [39] re-
ported that short bouts of MVPA (representing sMVPA
Table 3 Participant demographics displayed per lustrum of age. Data presented as Mean(SD), Median(IR), or geometric mean
Variable Age Group (years)
Pooled 60–65 66–71 72–77 78–83 84+
n 93 10 19 31 24 9
Female (%) 55 90 47 54 54 33
Covariates
Directly CVD Meds (n∙day− 1)a 1.17 (1.52) 0.30 (0.48) 0.74 (1.37) 1.39 (1.61) 1.39 (1.53) 1.78 (1.92)
(In)directly CVD Meds (n∙day−1)b 1.62 (1.81) 0.70 (0.67) 1.05 (1.51) 1.81 (1.97) 2.04 (1.92) 2.11 (1.96)
Inn+ (In)directly CVD Meds
(mg∙day−1)c
157.86 (486.49) 293.40 (797.89) 54.71 (73.39) 93.19 (293.99) 136.67 (323.71) 494.88 (1085.38)
BP Meds (mg∙day−1) 9.81 (50.79) 3.50 (6.73) 5.47 (13.29) 2.35 (4.89) 8.05 (16.71) 53.00 (154.35)
Lipid-Lowering Meds (mg∙day−1) 8.12 (16.58) 11.00 (16.63) 9.41 (15.60) 3.57 (10.96) 13.33 (23.09) 4.44 (13.33)
Cardio-metabolic Parameters
Triglyceride (mmol∙l−1) 1.77 (0.81)m 2.09 (0.86)m 1.51 (0.84)m 1.73 (0.68)m 1.88 (0.56)m 1.89 (0.57)m
Total Cholesterol (mmol∙l−1) 5.44 (1.39)m 6.06 (0.95) 5.64 (1.08) 5.45 (1.07) 5.64 (0.89) 5.27 (0.66)
Glucose (mmol∙l−1) 5.72 (1.10)m 5.81 (0.81)m 5.85 (1.35)m 5.60 (1.33)m 5.65 (1.38)m 6.00 (1.11)m
HbA1c (%) 5.29 (0.31) 5.18 (0.22) 5.30 (0.22) 5.34 (0.36) 5.24 (0.33) 5.38 (0.32)
LPL (pg∙mL−1) 113.02 (147.80)m 174.35 (277.28)m 119.13 (127.16)m 83.41 (123.97)m 117.88 (147.07)m 247.58 (332.56)m
IL-6 (pg∙mL−1) 2.72 (2.77)m 3.11 (1.85)m 2.39 (2.85)m 2.55 (3.29)m 2.36 (2.98)m 4.14 (6.00)m
PIIINP (pg∙mL−1) 229.21 (247.97)m 205.05 (239.21)m 229.21 (208.30)m 316.92 (228.81)m 167.19 (248.76)m 256.99 (406.27)m
sleep, sedentary behaviour, and physical activity parameters
Sleep (hrs∙day−1) 8.43 (0.77) 8.40g 7.88 (0.83) 7.84g 8.49 (0.53) 8.48g 8.41 (0.73) 8.35g 8.62 (0.79) 8.58g 8.50 (1.04) 8.45g
SB (hrs∙day−1) 9.65 (1.33) 9.56g 9.81 (1.31) 9.73g 9.34 (1.38) 9.25g 9.61 (1.36) 9.53g 9.59 (1.29) 9.51g 10.49 (1.15)
10.44g
Standing (hrs∙day−1) 1.09 (0.41) 1.02g 1.19 (0.30) 1.14g 1.16 (0.43) 1.08g 1.11 (0.39) 1.03g 1.08 (0.43) 1.00g 0.89 (0.43) 0.81g
LIPA (hrs∙day−1) 1.97 (0.63) 1.86g 2.11 (0.49)
2.05g
1.86 (0.59) 1.78g 2.06 (0.63) 1.95g 1.99 (0.68) 1.88g 1.73 (0.77) 1.57g
sMVPA (hrs∙day−1) 2.57 (0.64) 2.49g 2.68 (0.58) 2.62g 2.86 (0.56) 2.80g 2.55 (0.59) 2.49g 2.53 (0.69) 2.42g 2.07 (0.67) 1.96g
10MVPA (hrs∙day
−1) 0.08 (0.20)m
0.06g
0.06 (0.16)m
0.07g
0.15 (0.29)m
0.13g
0.08 (0.21)m
0.05g
0.09 (0.22)m
0.07g
0.07 (0.13)m
0.03g
10MVPA
d (hrs∙day−1) 0.48 (0.36) 0.40g 0.53 (0.30) 0.43g 0.47 (0.22) 0.43g 0.54 (0.51) 0.43g 0.39 (0.17) 0.35g 0.28 (0.09) 0.27g
a Participants are currently prescribed an amount of medication that reduces the risk or treats CVD (i.e. statins, warfarin). b Participants are currently prescribed a
medication that may affect the cardiovascular system either directly or as a side effect. c Participants are currently prescribed a medication that may affect the
cardiovascular system either directly or as a side effect, including inflammatory medication. d Excluding 49 participants who accumulated < 10min of 10MVPA in a
week (variable not used in CoDA). m Median (IR). g Geometric mean
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in the current study) were not sufficient to prevent an
increase in triglyceride concentration following meal in-
gestion. This was also notable in the present study, as
engagement in sMVPA in the ‘low’ and ‘high’ triglyceride
groups only deviated 2.3 and 1.9% from the entire study
sample, respectively, suggesting that sMVPA has little
influence on circulating triglyceride levels.
The pattern of time-use composition for total choles-
terol is not as clear within the current study. This is
likely due to total cholesterol containing lipoproteins
that have opposite responses to inactivity. Both triglycer-
ide and low-density lipids (LDL-C) increase in concen-
tration, whereas high-density lipids (HDL-C) decrease in
concentration, during detraining [38]. Therefore, it is
difficult to ascertain whether/which behaviour(s) are
affecting LDL-C and HDL-C profile. Future research,
should conduct CoDA with total cholesterol segregated
into HDL-C and LDL-C to provide a more precise
understand of the effects of sleep, sedentary behaviour,
and physical activity.
Overall, our results suggests that engagement in
10MVPA influences triglyceride concentration by pos-
sibly targeting LPL pathways. This finding advocates the
need for older adults to be ‘physically active’ in terms of
attaining sufficient 10MVPA, as defined in the 2011 UK
government PA guidelines, especially as LPL is already
reduced in older adults, compared to young adults [40].
Glucose metabolism
The prevalence of physical inactivity and SB, even in
acute episodes, has a marked influence on insulin in-
sensitivity and subsequently on reduced glucose uptake
[41–43], predominantly in skeletal muscle tissue [44].
Our results support this concept as those with a ‘high’
glucose concentration engaged in more sleep and SB,
and less PA (excluding sMVPA), compared to the entire
study sample. This increased circulating glucose concen-
tration is thought to be due to the reduced translocation
of glucose transporter type 4 (GLUT4) to the skeletal
muscle cell membrane [45] and reduced expression of
carbohydrate metabolism genes during bouts of reduced
muscle contractile activity (Sleep and SB) such as, cyto-
plasmic dynein light chain 1 (DYNLL1) [46] which, plays
a role in GLUT4 translocation [47]. Our results may also
suggest that habitual higher SB and lower PA engage-
ment can have a chronic effect on glucose homeostasis,
as participants with a ‘high’ HbA1c percentage also engaged
in more sleep and SB, and less 10MVPA, compared to the
Fig. 1 Compositional geometric mean bar plots displaying the difference in time-use composition between ‘low’ and ‘high’ cardio-metabolic
parameter sub-groups. a triglyceride (n ‘low’: 39, ‘high’: 50) b total cholesterol (n ‘low’: 30, ‘high’: 59), c glucose (n ‘low’: 57, ‘high’: 32), and d
HbA1c (n ‘low’: 13, ‘high’: 20). A positive Log Ratio indicates that a group engaged in more of a behaviour, in comparison with the entire study
sample. A negative Log Ratio indicates that a group engaged in less of a behaviour, in comparison with the entire study sample
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entire study sample (with other PA apparently having little
effect on HbA1c), when a mean HbA1c percentage group-
ing threshold was used. HbA1c represents a 1–3month
average of blood glucose concentration [48] and can be
used in the diagnosis of diabetes mellitus if blood tests ex-
ceed 6.5%. The results of the current study are consistent
with previous findings in older English adult populations (≥
60 years), which found HbA1c percentage increased as ob-
jective SB time increased from 8.45–9.52 h∙day− 1 to > 9.52
h∙day− 1 (5.8 [0.8], 6.0 [0.8]%, p = 0.01, respectively) and
reduced (0.13% [95%CI -0.24, − 0.03]) per 0.5 h∙day− 1 in-
crease in MVPA engagement [49]. Interestingly, in line with
our results, Stamatakis, Davis [49] also reported that LIPA
was not associated with HbA1c. Our results therefore sup-
port that PA has to be of at least moderate intensity in
order to maintain increased insulin sensitivity and subse-
quently glucose uptake, post-exercise [50].
Overall, the current study suggests that reduced SB
and increased PA could lead to acutely reduced blood
glucose concentration in older adults. However, to main-
tain a ‘healthier’ chronic glucose homeostasis, PA may
have to be of a moderate-vigorous intensity. Therefore,
we urge older adults to minimise SB engagement and
attain a ‘physically active’ lifestyle to increase the likeli-
hood of a ‘healthy’ glucose profile.
Inflammation and vascular stiffness
In older adults, IL-6 serum concentration is greater
compared to young adults [51] and is associated with an
increased risk of CVD [52]. The current study suggested
that a greater engagement in sleep and SB could be
beneficial towards the reduction in inflammation as
those with a ‘low’ IL-6 concentration engaged in 4.8 and
3.8% more sleep and SB, respectively, compared to the
entire study sample. This is in agreement with previous
older adult findings, which suggested that IL-6 concen-
tration reduced by 2.0 pg∙mL− 1 with a > 1.5 h reduction
in total awake time [53]. However, it was previously
illustrated that an hour increase in SB could increase IL-
6 by 0.24 (95%CI 0.13, 0.35) pg∙mL− 1 in older adults
[54]. The discrepancies between Henson, Yates [54] and
the current study may lie in the type of analysis. Henson,
Yates [54] used a multiple linear regression model,
which does not account for the influence of other behav-
iour(s) on IL-6 in the same way that CoDA does, and
may under-estimate the magnitude and direction of
Fig. 2 Compositional geometric mean bar plots displaying the difference in time-use composition between ‘low’ and ‘high’ cardio-metabolic
parameter sub-groups. a LPL (n ‘low’: 26, ‘high’: 57), b LPL normalised for inflammatory + CVD (in)directly targeting medication (n ‘low’: 21, ‘high’:
55), c IL-6 (n ‘low’: 33, ‘high’: 52), and d PIIINP (n ‘low’: 36, ‘high’: 37). A positive Log Ratio indicates that a group engaged in more of a behaviour,
in comparison with the entire study sample. A negative Log Ratio indicates that a group engaged in less of a behaviour, in comparison with the
entire study sample
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associations, when all other time-use compositions are
not accounted for [15]. It is thought that increases in
serum IL-6 is a result of increased IL-6 concentration
within the muscle, which occurs during repeated muscu-
lar contraction [55]. Therefore, it is possible to postulate
that an elevated amount of sleep engagement may be ne-
cessary for older adults to manage the inflammatory re-
sponse, as reduced engagement in sleep is associated
with an increase in IL-6 concentration and subsequently
increased pain ratings within healthy middle-aged adults
[56]. This relationship between pain and IL-6 may also
explain why the ‘low’ IL-6 group engage in more SB as
qualitative evidence stated that older adults’ main deter-
minant for engaging in SB is to reduce sensations of pain
[57]. However, given that those within ‘high’ ECMDR
groups (total cholesterol, triglyceride, glucose, and
HbA1c) appear to engage in more SB, compared to the
entire study sample, within the current study; it would
be advised that older adults engage in more sleep than
SB to improve IL-6 profile.
Increased PIIINP concentration is a marker of vascular
stiffness in older adults [30]. Within sleep, sedentary
behaviour, and physical activity research, there is an ap-
parent lack of investigations into changes in PIIINP (ex-
cluding resistance training). To the author’s knowledge,
only one study exists, which suggested 10-weeks of LIPA
and MVPA were not sufficient to cause a change in
middle-older adults’ (51–71 years) PIIINP concentration
[58]. Our results suggest that those with a ‘low’ PIIINP
concentration engage in a longer duration of all time-
use compositions (excluding 10MVPA), most noticeably
sleep, compared to the study sample and vice versa for
the ‘high’ PIIINP group, when a median concentration
grouping threshold is applied. The current study, there-
fore suggests that future research should examine the
associations between sleep, sedentary behaviour, and
physical activity and PIIINP in older adults to confirm
or refute whether sleep, sedentary behaviour, and phys-
ical activity interventions can help reduce vascular stiff-
ness through PIIINP pathways.
Public health implications
The key findings of this study suggest that older adults
who have a healthy cholesterol and glucose profile en-
gage in more 10MVPA and less SB than the entire study
sample, respectively. This adds to the evidence base
which supports the inclusion of the 10-min threshold
within the UK moderate intensity PA guideline. How-
ever, given such a low percentage of older adults achieve
the moderate intensity PA guidelines (when measured
with accelerometery) [59], our secondary finding offers
hope that older adults could be able to improve health
status by reducing SB, possibly a more palatable option
for the population and recommended in the 2019 Chief
Medical Officers’ UK Physical Activity Guidelines [60].
Recently, physical activity guidelines for Canada and
Australia have moved to considering 24-h time-use com-
position for children and young people. As CoDA research
continues to grow within adult-older adult populations, it
appears likely that there will also be a shift to 24-h guide-
line, which will provide end-users with a variety of options
to improve their health-status and thus partially remove the
more common one-size fits all approach physical activity
guidance.
There appeared to be a pattern across ECMDR vari-
ables where a sub-group who engaged in more 10MVPA
also engaged in less sMVPA and vice versa. It seems un-
likely that this apparent pattern between sMVPA and
10MVPA is due to co-dependence as the variation matrix
suggested a low co-dependence. Furthermore, without,
any direct insight through an experimental manipulation
of the two time-use components, it is difficult to put for-
ward a definitive argument to explain why sMVPA and
10MVPA appear to have opposing relationships with
cardiometabolic health markers. We can only speculate
that some markers are upregulated by the HIIT (high
intensity interval training) type stimulus (sMVPA) and
downregulated by the more continuous type of stimulus
(10MVPA), whilst other markers show the opposite sen-
sitivity. In our data pooling, we categorised activities by
threshold so it may be that the absolute amount of en-
ergy utilisation may have been higher within the MVPA
spectrum in the sMVPA bouts, and lower within this
MVPA spectrum in the 10MVPA bouts. In this event,
the fuel utilisation (hence endocrine) profiles of sMVPA
and 10MVPA would differ significantly [61].
Study Strengths & Limitations
The strengths of the study include: the use of an ‘object-
ive’, posture recognising accelerometer that utilised older
adult-relevant sleep, sedentary behaviour, and physical
activity intensity cut-off points from SB through to
MVPA. In fact, these cut-off points were developed
using a sub-sample of the current study’s participants.
Another strength is the use of CoDA, which took into
account the co-dependence of sleep, sedentary behav-
iour, and physical activity; and a third strength, the ap-
plication of time-use composition within older adult
populations, which has seldom been carried out.
Nonetheless, the main limiting factor of the current
study is the sample size, which constrained the analyses
to descriptive group comparisons rather than the more
statistically powered compositional regression analysis.
Although, the current study provided descriptive com-
parisons of the time-use composition of ‘healthy’ and
‘unhealthy’ sub-groups, the findings are limited to our
sample of participants. Future research is needed with
larger sample sizes, statistical difference testing, and
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longitudinal data from older adults to provide a compre-
hensive evidence base for generalisation at a population
level. Whilst our study sample was too small to do this,
and previous studies similar to ours did not attempt this
either [12, 13], we would recommend that future studies
using larger sample size should statistically determine
the significance of differences between sleep, sedentary
behaviour, and physical activity of the healthy compared
to unhealthy groups. It is possible that the differences
look large but are actually not statistically significant.
Such an approach would ideally utilise a modification of
the bootstrapping method as used in previous work [14].
Conclusion
CoDA revealed that all time-use components play a role
in the maintenance of cardio-metabolic profile. For a
‘healthy’ lipid profile, our results suggested that older
adults should attain a ‘physically active’ status, as
10MVPA engagement was greater in the ‘high’ LPL con-
centration group and subsequently greater in the ‘low’
triglyceride concentration group. For glucose homeosta-
sis, the current study recommended that older adults
should reduce their engagement in SB by engaging in
PA. In addition, it was suggested that being ‘physically
active’ may contribute to chronic glucose homeostasis,
as shown by the HbA1c results. Finally, a 4.8% (approxi-
mately 25 mins·day− 1, based on the geometric mean of
sleep for our study sample) increase in the amount of
sleep engagement may be essential for older adults to re-
duce inflammation, especially in episodes of pain, which
has been associated with increasing IL-6 concentration.
Overall, the current study recommends that older
adults should aim to be ‘physically active’ by engaging in
prolonged bouts of MVPA. However, in the remaining
hours of the day, they should aim to reduce SB (in spite
of the apparent benefit for IL-6), where possible (to min-
imise pain), by engaging in low intensity PA (standing
and LIPA), as these behaviours are highly co-dependent.
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